Jagsonpal Pharmaceuticals Inaugurates Dedicated Girls’ Toilet Facility in Punjab Under ‘MySakhi’ CSR Initiative

Date:

Share post:

Jagsonpal Pharmaceuticals Ltd. has officially inaugurated a dedicated Girls’ Toilet Facility at Govt. Senior Secondary School ,Saheed Mewa Singh School of Eminence in Morinda, District Rupnagar, Punjab, as part of its flagship Corporate Social Responsibility (CSR) program, MySakhi. The initiative aligns with the company’s core mission to construct healthier, safer, and more dignified learning environments for young girls across local communities. 

Recognizing that proper sanitation extends far beyond basic physical infrastructure, Jagsonpal Pharmaceuticals designed this project to directly address key social and health barriers that adolescent girls face in public education. Inadequate sanitation facilities frequently contribute to health issues, absenteeism, and early dropouts among school-aged girls. By establishing clean, secure, and private facilities, the MySakhi project ensures that female students can pursue uninterrupted schooling while promoting better hygiene, personal health, self-confidence, and dignity.

Through targeted CSR projects like MySakhi, JagsonpalPharmaceuticals continues to drive community development efforts focused on empowering women and girls. The company remains committed to advancing female education and community health, working under the belief that small, focused infrastructural improvements lead to lasting, meaningful social impact for future generations.

Written by: Pragna Biswas

Graphics by; Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

ViiV Healthcare Advances HIV Care with Breakthrough Long-Acting Injectable Data at AIDS 2026

ViiV Healthcare, the global specialist HIV company majority-owned by GSK plc, announced landmark clinical, real-world, and pipeline data...

Wockhardt Launches “Wockhardt Antibiotic Academy” to Tackle Growing Threat of Multidrug Resistance in India

Wockhardt Limited announced the launch of the Wockhardt Antibiotic Academy, a national initiative dedicated to fostering patient-centric scientific dialogue...

Optimus Pharma Secures Regulatory Approval for Non-Steroidal Tapinarof Cream to Treat Plaque Psoriasis

Optimus Pharma, a leading Indian pharmaceutical manufacturer and subsidiary of Sekhmet Pharmaventures, announced that it has received regulatory...

Enhertu Shows Better Results Than Standard Treatment in Lung Cancer Trial

AstraZeneca and Daiichi Sankyo announced that their antibody-drug conjugate Enhertu (trastuzumabderuxtecan) has achieved a statistically significant and clinically meaningful improvement...